Abiopharma

🔍 GOLDMAN KENNETH A (Executive)

Company: Fortinet, Inc. (FTNT)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 649 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 22,819.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: By Goldman-Valeriote Family Trust u/a/d 11/15/95 | shares_owned_after: 20,750.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: By GV Partners L.P. | shares_owned_after: 1,000.00 | Footnotes: F3
• Sold 649 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 650.00 | transaction_form_type: 4 | Footnotes: F4, F1, F5, F6

Footnotes:

• F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2025.
• F2: The Reporting Person is a trustee of the Trust and may be deemed to have voting and dispositive power with regard to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of his pecuniary interest therein.
• F3: GV Partners L.P. is a family limited partnership of which the Reporting Person is the managing member.
• F4: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.
• F5: The RSUs will vest in substantially equal increments on each of September 30, 2025, December 31, 2025, March 31, 2026, and the earlier of (i) June 30, 2026 and (ii) the date immediately preceding the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting.
• F6: RSUs do not expire; they either vest or are canceled prior to vest date